TP53 and cancer: Depending of genetic status of tumor nutlin-3 might be administrated as an agent for activation of the p53 pathway resulting in p53 stabilization, p21 induction, cell cycle arrest in G1 and G2 phases, apoptosis and growth inhibition of cancer cells or in combination with taxol as a compound protecting surrounding normal tissue.